首页 › 非小细胞肺癌 › 密歇根州 › Grand Rapids
Grand Rapids MI 非小细胞肺癌临床试验
44项针对 非小细胞肺癌的研究正在 Grand Rapids及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of ZW251 in Participants With Advanced Solid Tumors
招募中1 期
- START Midwest, Grand Rapids
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
招募中3 期
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
招募中1 期
- START - Midwest, Grand Rapids
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
招募中1 期
- South Texas Accelerated Research Therapeutics (START), Grand Rapids
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
招募中3 期
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
招募中1/2 期
- BAMF Health, Grand Rapids
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
招募中1 期
- ALX Center 3, Grand Rapids
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
招募中3 期
- Corewell Health - Butterworth Hospital, Grand Rapids
- Corewell Health - Lemmen Holton Cancer Pavilion, Grand Rapids
- Corewell Health - Research Specimen Processing Area, Grand Rapids
- 以及另外 2 项
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
招募中2 期
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Pan-tumor MRD Study
招募中观察性研究
- The Cancer & Hematology Centers (CHC), Grand Rapids
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
招募中3 期
- Research Site, Grand Rapids
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
招募中1/2 期
- START Midwest, Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- START Midwest, Grand Rapids
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
招募中3 期
- Research Site, Grand Rapids
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
招募中1/2 期
- START Midwest, Grand Rapids
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
招募中1 期
- START Midwest, Grand Rapids
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
招募中1 期
- BAMF Health, Grand Rapids
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
招募中1/2 期
- South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
招募中2/3 期
- Cancer & Hematology Centers of Western Michigan - East /ID# 261826, Grand Rapids
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
招募中观察性研究
- Cancer & Hematology Centers of Western Michigan, Grand Rapids
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
招募中1/2 期
- START | Midwest, Grand Rapids
A Phase 1/1b Study of IAM1363 in HER2 Cancers
招募中1 期
- START - Midwest Cancer Research Center, Grand Rapids
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- The Cancer & Hematology Centers, Grand Rapids
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
招募中1 期
- South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
招募中1 期
- START Midwest, Grand Rapids
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
招募中1 期
- The Cancer & Hematology Centers, Grand Rapids
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
招募中1/2 期
- START Midwest, LLC, Grand Rapids
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
招募中1 期
- South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
招募中1/2 期
- Research Site, Grand Rapids
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
招募中1/2 期
- START Midwest, Grand Rapids
A Study of MGC026 in Participants With Advanced Solid Tumors
招募中1 期
- START Midwest, Grand Rapids
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
招募中1 期
- START - Midwest, Grand Rapids
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
招募中1/2 期
- START Midwest, Grand Rapids
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
招募中1 期
- BAMF Health, Grand Rapids
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
招募中1 期
- START Midwest, Grand Rapids
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
招募中1 期
- START Midwest /ID# 248685, Grand Rapids
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
招募中1 期
- START Midwest, Grand Rapids
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中观察性研究
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
招募中1/2 期
- START Midwest, Grand Rapids
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
招募中1/2 期
- START, Midwest, Grand Rapids
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
招募中1/2 期
- START Midwest, Grand Rapids
其他城市的 非小细胞肺癌试验
- Houston, TX145 项研究
- New York City, NY121 项研究
- Arlington, VA104 项研究
- Nashville, TN97 项研究
- Boston, MA90 项研究
- Los Angeles, CA87 项研究
- St. Louis, MO73 项研究
- Chicago, IL61 项研究
- Baltimore, MD60 项研究
- San Antonio, TX59 项研究
- Columbus, OH57 项研究
- Washington, DC55 项研究
Grand Rapids的其他研究
- 结直肠癌40 项研究
- 癌症（所有类型）28 项研究
- 乳腺癌26 项研究
- 卵巢癌24 项研究
- 转移性癌症22 项研究
- 前列腺癌19 项研究
- 子宫内膜癌18 项研究
- 胃癌18 项研究
- 胰腺癌18 项研究
- 黑色素瘤17 项研究
- 头颈鳞状细胞癌15 项研究
- 三阴性乳腺癌15 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。